Paper Review Records
全部论文审稿周期
10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
16
天
Peptide-based pan-CoV fusion inhibitors maintain high potency against SARS-CoV-2 Omicron variant
作者
Shuai Xia; Jasper Fuk-Woo Chan; Lijue Wang; Fanke Jiao; Kenn Ka-Heng Chik; Hin Chu; Qiaoshuai Lan; Wei Xu; Qian Wang; Chao Wang; Kwok-Yung Yuen; Lu Lu; Shibo Jiang展开收起
作者单位
1. Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Shanghai Frontiers Science Center of Pathogenic Microbes and Infection, Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China; 2. State Key Laboratory of Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, China; 3. Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China; 4. Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong, China; 5. State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China展开收起
96
天
Heterogeneity in endothelial cells and widespread venous arterialization during early vascular development in mammals
作者
Siyuan Hou; Zongcheng Li; Ji Dong; Yun Gao; Zhilin Chang; Xiaochen Ding; Shuaili Li; Yunqiao Li; Yang Zeng; Qian Xin; Baihan Wang; Yanli Ni; Xiaowei Ning; Yuqiong Hu; Xiaoying Fan; Yu Hou; Xianlong Li; Lu Wen; Bin Zhou; Bing Liu; Fuchou Tang; Yu Lan展开收起
作者单位
1. Key Laboratory for Regenerative Medicine of Ministry of Education, Institute of Hematology, School of Medicine, Jinan University, Guangzhou, China; 2. State Key Laboratory of Experimental Hematology, Haihe Laboratory of Cell Ecosystem, Institute of Hematology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China; 3. Integrated Chinese and Western Medicine Postdoctoral Research Station, Jinan University, Guangzhou, China; 4. Beijing Advanced Innovation Center for Genomics and Biomedical Pioneering Innovation Center, School of Life Sciences, Peking University, Beijing, China; 5. State Key Laboratory of Proteomics, Academy of Military Medical Sciences, Academy of Military Sciences, Beijing, China; 6. Ministry of Education Key Laboratory of Cell Proliferation and Differentiation, Beijing, China; 7. The State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China; 8. Peking-Tsinghua Center for Life Sciences, Peking University, Beijing, China展开收起
8
天
Reduced interferon antagonism but similar drug sensitivity in Omicron variant compared to Delta variant of SARS-CoV-2 isolates
作者
Denisa Bojkova; Marek Widera; Sandra Ciesek; Mark N. Wass; Martin Michaelis; Jindrich Cinatl展开收起
作者单位
1. Institute for Medical Virology, University Hospital, Goethe University, Frankfurt am Main, Germany; 2. German Center for Infection Research, DZIF, External Partner Site Frankfurt am Main, Frankfurt am Main, Germany; 3. Fraunhofer Institute for Molecular Biology and Applied Ecology (IME), Branch Translational Medicine und Pharmacology, Frankfurt am Main, Germany; 4. School of Biosciences, University of Kent, Canterbury, UK; 5. Dr. Petra Joh-Forschungshaus, Frankfurt am Main, Germany展开收起
5
天
SARS-CoV-2 Omicron variant is highly sensitive to molnupiravir, nirmatrelvir, and the combination
作者
Pengfei Li; Yining Wang; Marla Lavrijsen; Mart M. Lamers; Annemarie C. de Vries; Robbert J. Rottier; Marco J. Bruno; Maikel P. Peppelenbosch; Bart L. Haagmans; Qiuwei Pan展开收起
作者单位
1. Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands; 2. Viroscience Department, Erasmus MC-University Medical Center, Rotterdam, the Netherlands; 3. Department of Pediatric Surgery, Erasmus MC-Sophia Children’s Hospital, Rotterdam, the Netherlands; 4. Department of Cell Biology, Erasmus MC-University Medical Center, Rotterdam, the Netherlands展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天